Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study

Mockenhaupt, Maja; Viboud, Cecile; Dunant, Ariane; Naldi, Luigi; Halevy, Sima; Bouwes Bavinck, Jan Nico; Sidoroff, Alexis; Schneck, Jurgen; Roujeau, Jean-Claude; Flahault, Antoine

doi:10.1038/sj.jid.5701033

Scientific article

English

Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study

ContributorsMockenhaupt, Maja; Viboud, Cecile; Dunant, Ariane; Naldi, Luigi; Halevy, Sima; Bouwes Bavinck, Jan Nico; Sidoroff, Alexis; Schneck, Jurgen; Roujeau, Jean-Claude; Flahault, Antoine

Published inJournal of investigative dermatology, vol. 128, no. 1, p. 35-44

Publication date2008

Keywords

Adrenal Cortex Hormones/adverse effects
Adult
Aged
Analgesics/adverse effects
Case-Control Studies
Humans
Middle Aged
Nevirapine/adverse effects
Risk
Sertraline/adverse effects
Stevens-Johnson Syndrome/*etiology
Time Factors
Triazines/adverse effects

Affiliation entities

Not a UNIGE publication

Citation (ISO format)

MOCKENHAUPT, Maja et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. In: Journal of investigative dermatology, 2008, vol. 128, n° 1, p. 35–44. doi: 10.1038/sj.jid.5701033

Article (Published version)

Identifiers

PID : unige:47156
DOI : 10.1038/sj.jid.5701033
PMID : 17805350

Journal ISSN0022-202X

641views

1downloads

Creation23/02/2015 14:34:58

First validation23/02/2015 14:34:58

Update time14/03/2023 22:54:25

Status update14/03/2023 22:54:25

Last indexation30/10/2024 23:04:37

Archive ouverte UNIGE

Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study

Technical informations